These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease. Carp JM, Onuma E, Das K, Gottlieb AB. Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617 [Abstract] [Full Text] [Related]
3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D. Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [Abstract] [Full Text] [Related]
4. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease. Argüelles-Arias F, Castro-Laria L, Lobatón T, Aguas-Peris M, Rojas-Feria M, Barreiro-de Acosta M, Soto-Escribano P, Calvo-Moya M, Ginard-Vicens D, Chaparro-Sánchez M, Hernández-Durán M, Castro-Senosiain B, Fernández-Villaverde A, García-Sánchez V, Domínguez-Muñoz E, Caunedo-Álvarez A, Herrerías-Gutiérrez JM. Dig Dis Sci; 2013 Oct; 58(10):2949-54. PubMed ID: 23828140 [Abstract] [Full Text] [Related]
5. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine. Futami H, Kodaira M, Furuta T, Hanai H, Kaneko E. J Gastroenterol; 1998 Jun; 33(3):408-11. PubMed ID: 9658322 [Abstract] [Full Text] [Related]
6. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338 [Abstract] [Full Text] [Related]
7. Case Report: Triple Combination Therapy for Recalcitrant Perineal Pyoderma Gangrenosum. Shaath TS, Om A, Wolfe CM, Cohen GF. J Drugs Dermatol; 2019 Mar 01; 18(3):307-310. PubMed ID: 31020825 [Abstract] [Full Text] [Related]
8. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease. Ramakrishna J, Langhans N, Calenda K, Grand RJ, Verhave M. J Pediatr Gastroenterol Nutr; 1996 Apr 01; 22(3):296-302. PubMed ID: 8708884 [Abstract] [Full Text] [Related]
10. Treatment of pyoderma gangrenosum with cyclosporine. Matis WL, Ellis CN, Griffiths CE, Lazarus GS. Arch Dermatol; 1992 Aug 01; 128(8):1060-4. PubMed ID: 1497359 [Abstract] [Full Text] [Related]
11. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013. Barbosa NS, Tolkachjov SN, El-Azhary RA, Davis MD, Camilleri MJ, McEvoy MT, Bridges AG, Wetter DA. J Am Acad Dermatol; 2016 Nov 01; 75(5):931-939. PubMed ID: 27473454 [Abstract] [Full Text] [Related]
12. Management of peristomal pyoderma gangrenosum. Poritz LS, Lebo MA, Bobb AD, Ardell CM, Koltun WA. J Am Coll Surg; 2008 Feb 01; 206(2):311-5. PubMed ID: 18222385 [Abstract] [Full Text] [Related]
13. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases]. Dejaco C, Gasché C, Reinisch W, Moser G, Novacek G, Tillinger W, Vogelsang H, Gangl A. Wien Klin Wochenschr; 1998 Sep 04; 110(16):579-84. PubMed ID: 9782579 [Abstract] [Full Text] [Related]
16. Vulvar pyoderma gangrenosum in a child. Garcovich S, Gatto A, Ferrara P, Garcovich A. Pediatr Dermatol; 2009 Nov 04; 26(5):629-31. PubMed ID: 19840334 [Abstract] [Full Text] [Related]
17. Combination immunomodulatory therapy with cyclosporine and azathioprine in corticosteroid-resistant severe ulcerative colitis: the Edinburgh experience of outcome. Campbell S, Ghosh S. Dig Liver Dis; 2003 Aug 04; 35(8):546-51. PubMed ID: 14567458 [Abstract] [Full Text] [Related]